NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice

Pharmacological Reports

Volumn 65, Issue 5, 2013, Pages 1124-1131

  Poleszak, Ewa ^a   Serefko, Anna ^a   Szopa, Aleksandra ^a   Wooeko, Sylwia ^a   Dudka, Jaroslaw ^b   Wróbel, Andrzej ^a   Oniszczuk, Tomasz ^c   Wlaÿ, Piotr ^d  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Medical Biology Unit   (United Kingdom)

^c UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^d MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Anxiety; Elevated plus maze test; Mice; NMDA receptor ligands

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; MALE; MOUSE; NONHUMAN; TRANQUILIZING ACTIVITY;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BINDING SITES; BRAIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; GLYCINE; LIGANDS; MALE; MAZE LEARNING; MICE; N-METHYLASPARTATE; QUINOLONES; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE;

EID: 84894219179     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71470-1     Document Type: Article

References (45)

1. Adamec RE, Burton P, Shallow T, Budgell J: Unilateral block of NMDAreceptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle-effective hemisphere depends on the behavior. Physiol Behav, 1999, 65, 739-751. (Pubitemid 29094710)
2. Barkus C, McHugh SB, Sprengel R, Seeburg PH, Rawlins JN, Bannerman DM: Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion. Eur J Pharmacol, 2010, 626, 49-56.
3. Beardsley PM, Ratti E, Balster RL, Willetts J, Trist D: The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects. Behav Pharmacol, 2002, 13, 583-592. (Pubitemid 35387418)
4. Cotman CW, Monaghan DT: Anatomical organization of excitatory amino acid receptors and their properties. Adv Exp Med Biol, 1986, 203, 237-252.
5. Cruz AP, Frei F, Graeff FG: Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav, 1994, 49, 171-176. (Pubitemid 24297273)
6. DanyszW, Parsons CG: Glycine and N-methyl-D-aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacol Rev, 1998, 50, 597-664.
7. Dawson GR, Crawford SP, Collinson N, Iversen SD, Tricklebank MD: Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berl), 1995, 118, 316-323.
8. Dawson GR, Crawford SP, Stanhope KJ, Iversen SD, Tricklebank MD: One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology (Berl), 1994, 113, 570-572. (Pubitemid 24150513)
9. Erreger K, Chen PE, Wyllie DJ, Traynelis SF: Glutamate receptor gating. Crit Rev Neurobiol, 2004, 16, 187-224. (Pubitemid 40314700)
10. Guimaraes FS, Carobrez AP, De Aguiar JC, Graeff FG: Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berl), 1991, 103, 91-94.
11. Javitt DC: Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry, 2004, 9, 984-979.
12. Jessa M, Nazar M, Bidziñski A, Panik A: The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety. Eur Neuropsychopharmacol, 1996, 6, 55-61. (Pubitemid 26100034)
13. Kaster MP, Machado DG, Santos AR, Rodrigues AL: Involvement of NMDA receptors in the antidepressant-like action of adenosine. Pharmacol Rep, 2012, 64, 706-713.
14. Kemp JA, Leeson PD: The glycine site of the NMDA receptor-five years on. Trends Pharmacol Sci, 1993, 14, 20-25. (Pubitemid 23034603)
15. Kleckner NW, Dingledine R: Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science, 1988, 241, 835-837.
16. Kolasiewicz W, Maj J: Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849. Pol J Pharmacol, 1996, 48, 467-479. (Pubitemid 26426006)
17. Kotliñska J, Liljequist S: A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324. Psychopharmacology (Berl), 1998, 135, 175-181. (Pubitemid 28055501)
18. Labrie V, Clapcote SJ, Roder JC: Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors. Pharmacol Biochem Behav, 2009, 91, 610-620.
19. Lin HQ, Burden PM, ChristieMJ, Johnston GA: The anxiogenic-like and anxiolytic-like effects ofMDMAon mice in the elevated plus-maze: A comparison with amphetamine. Pharmacol Biochem Behav, 1999, 62, 403-408. (Pubitemid 29117180)
20. Lipman JJ, Spencer PS: Rapid intracerebroventricular injection assisted by an automatic syringe. J Pharmacol Methods, 1980, 4, 327-333. (Pubitemid 11125776)
21. Lister RG: Ethologically based animal models of anxiety disorders. In: Psychopharmacology of anxiolytics and antidepressants. Ed. File SE, Pergamon Press, New York, 1991.
22. Lister RG: The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl), 1987, 92, 180-185. (Pubitemid 17072893)
23. Molchanov ML, Guimaraes FS: Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats. Psychopharmacology (Berl), 2002, 160, 30-38. (Pubitemid 34169823)
24. Nascimento Hackl LP, Carobrez AP: Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats. Neurobiol Learn Mem, 2007, 88, 177-185. (Pubitemid 47223755)
25. Niewoehner B, Single FN, Hvalby Ø, Jensen V, Meyer zum Alten Borgloh S, Seeburg PH, Rawlins JN et al.: Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J Neurosci, 2007, 25, 837-846.
26. Padovan CM, Del Bel EA, Guimaraes FS: Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: Influence of restraint stress. Pharmacol Biochem Behav, 2000, 67, 325-330. (Pubitemid 32000838)
27. Pellow S, Chopin P, File SE, Briley M: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 1985, 14, 149-167. (Pubitemid 16239568)
28. Panik A, PalejkoW, Nazar M, Jessa M: Effects of antagonists at the NMDAreceptor complex in two models of anxiety. Eur Neuropsychopharmacol, 1994, 4, 503-512.
29. Poleszak E, Socaa K, Szopa A, Wróbel A, Szewczyk B, Kasperek R, Blicharska E et al.: Involvement of NMDA receptor complex in the anxiolytic-like effects of chlordiazepoxide in mice. J Neural Transm, 2011, 118, 857-864.
30. Poleszak E, Szewczyk B, Wla A, Fidecka S, Wla P, Pilc A, Nowak G: D-serine, a selective glycine/Nmethyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol Rep, 2008, 60, 996-1000.
31. Poleszak E, Wla P, Szewczyk B, Wla A, Kasperek R, Wróbel A, Nowak G: A complex interaction between glycine/NMDA receptors and serotonergic/ noradrenergic antidepressants in the forced swim test in mice. J Neural Transm, 2011, 118, 1535-1546.
32. Poleszak E, Wla P, Wróbel A, Dybaa M, Sowa M, Fidecka S, Pilc A, Nowak G: Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep, 2007, 59, 595-600.
33. Popik P, Wróbel M, Nowak G: Chronic treatment with antidepressants affects glycine/NMDA receptor function: Behavioral evidence. Neuropharmacology, 2000, 39, 2278-2287. (Pubitemid 30642770)
34. Priestley T, Laughton P, Macaulay AJ, Hill RG, Kemp JA: Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324. Neuropharmacology, 1996, 35, 1573-1581. (Pubitemid 27031000)
35. Przegaliñski E, Tatarczyñska E, Chojnacka-Wójcik E: Anxiolytic-and antidepressant-like effects of an antagonist at glycineB receptors. Pol J Pharmacol, 1998, 50, 349-354.
36. Przegaliñski E, Tatarczyñska E, Chojnacka-Wójcik E: The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology, 2000, 39, 1858-1864. (Pubitemid 30398489)
37. Ramos A, Mormede P: Stress and emotionality: A multidimensional and genetic approach. Neurosci Biobehav Rev, 1998, 22, 33-57. (Pubitemid 28082283)
38. Reynolds IJ, Miller RJ: Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol, 1988, 33, 581-584.
39. Rodgers RJ, Dalvi A: Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev, 1997, 21, 801-810. (Pubitemid 27524775)
40. Skolnick P, Popik P, Trullas R: Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci, 2009, 30, 563-569.
41. Szakacs R, Janka Z, Kalman J: The "blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depression. Neuropsychopharmacol Hung, 2012, 14, 29-40.
42. von Engelhardt J, Doganci B, Jensen V, Hvalby Ø, Gongrich C, Taylor A, Barkus C et al.: Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron, 2008, 60, 846-860.
43. Waxman EA, Lynch DR: N-methyl-D-aspartate receptor subtypes: Multiple roles in excitotoxicity and neurological disease. Neuroscientist, 2005, 11, 37-49. (Pubitemid 40223089)
44. Yee BK, Zhu SW, Mohammed AH, Feldon J: Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety-and fear-related behaviour in C57BL6 mice. J Neural Transm, 2007, 114, 431-444. (Pubitemid 46474856)
45. Zarate CA, Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 2006, 63, 856-864. (Pubitemid 44188478)